微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 68.03% | 1.25% | 4.41% | 1/51 | 35.76% | 南华生物 | 68.03% | 行业排名> |
| 2024-06-30 | 65.16% | -1.76% | 0.95% | 2/51 | 35.89% | 百诚医药 | 68.75% | 行业排名> |
| 2024-03-31 | 64.55% | -6.06% | -3.94% | 3/51 | 35.75% | 百诚医药 | 68.19% | 行业排名> |
| 2023-09-30 | 67.19% | 9.87% | 1.3% | 3/51 | 39.87% | 药康生物 | 67.61% | 行业排名> |
| 2023-06-30 | 66.33% | 21.15% | -3.46% | 3/51 | 39.77% | 药康生物 | 69.14% | 行业排名> |
| 2023-03-31 | 68.71% | 51.92% | 6.04% | 2/51 | 38.93% | 药康生物 | 68.49% | 行业排名> |
| 2022-12-31 | 64.79% | -8.53% | 5.94% | 3/51 | 40.1% | 药康生物 | 69.3% | 行业排名> |
| 2022-09-30 | 61.16% | -27.65% | 11.7% | 3/51 | 41.1% | 药康生物 | 71.38% | 行业排名> |
| 2022-06-30 | 54.75% | -34.19% | 21.06% | 5/51 | 39.96% | 药康生物 | 73.27% | 行业排名> |
| 2022-03-31 | 45.23% | -46.1% | -36.15% | 20/51 | 38.57% | 药康生物 | 75.32% | 行业排名> |
| 2021-12-31 | 70.83% | 27.57% | -16.2% | 2/51 | 41.94% | 药康生物 | 76.7% | 行业排名> |
| 2021-09-30 | 84.53% | 71.71% | 1.6% | 1/51 | 43.07% | 药康生物 | 74.33% | 行业排名> |
| 2021-06-30 | 83.19% | 5.65% | -0.85% | 1/51 | 42.6% | 南华生物 | 84.53% | 行业排名> |
| 2021-03-31 | 83.9% | 4.73% | 51.11% | 1/51 | 39.47% | 南华生物 | 83.19% | 行业排名> |
| 2020-12-31 | 55.52% | -11.82% | 12.79% | 10/51 | 38.51% | 南华生物 | 83.9% | 行业排名> |
| 2020-09-30 | 49.23% | -29.92% | -37.48% | 7/51 | 37.76% | 成都先导 | 79.36% | 行业排名> |
| 2020-06-30 | 78.74% | 13.17% | -1.71% | 1/51 | 39.28% | 成都先导 | 75.92% | 行业排名> |
| 2020-03-31 | 80.12% | 26.98% | 27.23% | 2/51 | 33.2% | 南华生物 | 78.74% | 行业排名> |
| 2019-12-31 | 62.97% | -4.32% | -10.35% | 3/51 | 42.94% | 成都先导 | 80.82% | 行业排名> |
| 2019-09-30 | 70.24% | 5.17% | 0.95% | 3/51 | 44.61% | 成都先导 | 81.55% | 行业排名> |
| 2019-06-30 | 69.58% | 3.9% | 10.28% | 3/51 | 45.09% | 海特生物 | 84.37% | 行业排名> |
| 2019-03-31 | 63.09% | 12.52% | -4.13% | 3/51 | 43.51% | 海特生物 | 87.74% | 行业排名> |
| 2018-12-31 | 65.81% | 149.1% | -1.46% | 2/51 | 42.09% | 海特生物 | 88.04% | 行业排名> |
| 2018-09-30 | 66.78% | 210.12% | -0.28% | 2/51 | 43.61% | 海特生物 | 92.52% | 行业排名> |
| 2018-06-30 | 66.97% | 139.58% | 19.43% | 2/51 | 43.98% | 海特生物 | 94.18% | 行业排名> |
| 2018-03-31 | 56.07% | 162.35% | 112.24% | 5/51 | 45.58% | 海特生物 | 94.39% | 行业排名> |
| 2017-12-31 | 26.42% | -18% | -5.48% | 38/51 | 40.94% | 海特生物 | 94.57% | 行业排名> |
| 2017-06-30 | 27.95% | 255.81% | 30.79% | 27/51 | 43.6% | 退市海医 | 87.54% | 行业排名> |
| 2017-03-31 | 21.37% | 298.12% | -33.66% | 20/51 | 38.7% | 海特生物 | 95.31% | 行业排名> |
| 2016-12-31 | 32.22% | 198.59% | 310.11% | 24/51 | 40.43% | 退市海医 | 91.85% | 行业排名> |
| 2016-06-30 | 7.86% | -13.41% | 172.82% | 22/51 | 33.77% | 海特生物 | 95.45% | 行业排名> |
| 2016-03-31 | -10.79% | 88.72% | -199.98% | 19/51 | 28.42% | 退市海医 | 96.32% | 行业排名> |
| 2015-12-31 | 10.79% | -59.75% | 18.93% | 28/51 | 37.17% | 海特生物 | 95.35% | 行业排名> |
| 2015-06-30 | 9.07% | -65.62% | 109.49% | 19/51 | 32.07% | 退市海医 | 95.27% | 行业排名> |
| 2015-03-31 | -95.65% | -1023.08% | -456.82% | 20/51 | 24.2% | 盈康生命 | 75.69% | 行业排名> |